Doximity, Inc. DOCS
Nov 13, 2026, 10:49 AM EST
- YTD
- -25.61%
- 1 year
- -33.75%
- Market cap
- 5.88B
- Revenue (ttm)
- 661.58M
- Profit margin
- 21.12%
- EPS (ttm)
- 0.72
- Shares out
- 127.52M
- P/E ratio
- 45.75
- Forward P/E
- 21.42
- YTD return
- -25.61%
- 1-year return
- -33.75%
- Volume
- 200.63K
- Avg volume
- 2.86M
- Open
- 33.51
- Previous close
- 33.20
- Day's range
- 32.79 – 33.57
- 52-week range
- 17.15 – 51.85
- Beta
- 1.29
- Analysts
- Hold
- Price target
- 31.22 (-5.2%)
- Earnings date
- Feb 4, 2027
5D +1.43 (+4.47%)
Key statistics
- Enterprise value
- 5.22B
- PEG ratio
- 0.59
- Price / sales
- 8.96
- Price / book
- 6.38
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 3.60%
- Free cash flow
- 292.15M
- Total cash
- 713.23M
- Total debt
- 9.15M
- Return on equity
- 13.81%
- Short % of float
- 5.57%
- 50-day average
- 29.47
- 200-day average
- 25.25
Analyst view
Consensus: hold
- Target (low)
- 18.00
- Target (mean)
- 31.22
- Target (high)
- 41.00
- Strong buy5
- Buy3
- Hold11
- Sell1
- Strong sell1
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 0.44476.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 0.41 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | 0.3483 | 0.36 | +0.01 | +3.36% |
| Aug 6, 2026 | Jun 30, 2026 | 0.303 | 0.29 | -0.01 | -4.29% |
| May 13, 2026 | Mar 31, 2026 | 0.28 | 0.26 | -0.02 | -7.14% |
| Feb 5, 2026 | Dec 31, 2025 | 0.44 | 0.46 | +0.02 | +4.55% |
| Nov 6, 2025 | Sep 30, 2025 | 0.3787 | 0.45 | +0.07 | +18.83% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Nov 10, 2026 | Freedom Capital Markets | main | Hold | Hold |
| Nov 6, 2026 | Canaccord Genuity | main | Buy | Buy |
| Nov 6, 2026 | RBC Capital | main | Outperform | Outperform |
| Nov 6, 2026 | Evercore ISI Group | main | In-Line | In-Line |
| Nov 6, 2026 | Needham | reit | Buy | Buy |
About Doximity, Inc.
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- doximity.com
News
Doximity to Provide New Clinical AI Tools Across NewYork-Presbyterian, Columbia University and Weill Cornell Medicine 
DOXIMITY DEADLINE: ROSEN, REGARDED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS 
Kaplan Fox Encourages Doximity, Inc. (DOCS) Investors Seeking Recovery to Contact the Firm Before November 16, 2026 
What's Next for Doximity, Inc. Shareholders After 23% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline 
Deadline Alert: Doximity, Inc. Investors Have Until November 16, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors 
What's Next for Doximity, Inc. Shareholders After 23% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline 
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm 
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS 
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law 
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Doximity, Inc. Lawsuit - DOCS
Your note
Sign in to keep a note on DOCS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BENJAMIN REGINA M. | Director | Stock Award(Grant) | Aug 26, 2026 | 58,987 |
| BRYSON ANNA COLLINS | Chief Financial Officer | Stock Award(Grant) | Feb 12, 2026 | 505,549 |
| CABRAL TIMOTHY S | Director | Sale | Nov 4, 2026 | 8,084 |
| SITARAM SIDDHARTH | Officer | Sale | Sep 14, 2026 | 96,045 |
| SPAIN KEVIN | Director | Stock Award(Grant) | Aug 26, 2026 | 644,751 |
| TANGNEY JEFFREY A. | Chief Executive Officer | Stock Award(Grant) | May 14, 2026 | 2,540,460 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.22% | 14,307,116 | 475.14M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.01% | 6,387,099 | 212.12M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.69% | 5,977,433 | 198.51M | Jun 29, 2026 |
| Shaw D.E. & Co., Inc. | 4.64% | 5,922,188 | 196.68M | Jun 29, 2026 |
| Two Sigma Investments, LP | 3.64% | 4,647,309 | 154.34M | Jun 29, 2026 |
| State Street Corporation | 3.30% | 4,210,909 | 139.84M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.55% | 4,531,649 | 150.50M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.29% | 4,198,955 | 139.45M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.38% | 3,031,092 | 100.66M | Jun 29, 2026 |
| Vanguard Explorer Fund | 1.68% | 2,147,510 | 71.32M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.37% | 1,747,294 | 58.03M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.21% | 1,538,120 | 51.08M | Jun 29, 2026 |